01

<01>

Leap Therapeutics, Inc. (LPTX), a biotechnology company focused on targeted and immuno-oncology therapeutics, announced Thursday updated positive data from the DisTinGuish Study of DKN-01 Plus ...

Source : https://www.nasdaq.com/articles/leap-therapeutics-reports-updated-positive-data-from-distinguish-study-of-dkn-01-plus

7
Leap Therapeutics Reports Updated Positive Data From DisTinGuish Study Of DKN-01 Plus Tislelizumab

Source:Nasdaq

Leap Therapeutics Reports Updated Positive Data From DisTinGuish Study Of DKN-01 Plus Tislelizumab

Invetx Announces Initiation of First Clinical Study in Dogs with IVX-01, its Novel Monoclonal Antibody Featuring Half-Life Extension

Source:Argus-Press

Invetx Announces Initiation of First Clinical Study in Dogs with IVX-01, its Novel Monoclonal Antibody Featuring Half-Life Extension

HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA in Combination with TUOYI in the Treatment of Advanced Neuroendocrine Carcinoma in China

Source:wallstreet online

HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA in Combination with TUOYI in the Treatment of Advanced Neuroendocrine Carcinoma in China

Luis "figalex25" Figallo Defeats “CBons 72” Heads-Up to Win WCOOP-01-H: $109 NLHE

Source:PokerNews

Luis "figalex25" Figallo Defeats “CBons 72” Heads-Up to Win WCOOP-01-H: $109 NLHE